• Skip to main content

DistilGovHealth

DistilNFO GovHealth Advisory

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Medicare drug plans can plan on rebates in 2020, CMS says

Share:

April 17, 2019

DATE: April 5, 2019

TO: Part D Plan Sponsors

FROM: Seema Verma Administrator

SUBJECT: Guidance Regarding Part D Bids

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

On february 6, 2019, the department of health and human services published a proposed rule that would expressly exclude from safe harbor protection under the anti-kickback statute rebates on prescription drugs paid by manufacturers to part d plan sponsors, medicaid managed care organizations, and pharmacy benefit managers under contract with them. The rule also proposed the creation of two new safe harbors. The comment period for the proposed rule closes on april 8th.

If there is a change in the safe harbor rules effective in 2020, cms wil l conduct a demonstration that would test a n efficient transition for beneficiaries and plans to such a change in the part d program. The demonstration would consist of a modification to the part d risk corridors for plans for which a bid is submitted. For cy2020, under the demonstration, the government would bear or retain 95% of the deviation between the target amount, as defined in section 1860d-15(e)(3)(b) of the social security act (the act) and the actual incurred costs, as defined in section 1860d-15(e)(1) of the act, beyond the first 0.5%. Participation in the two-year demonstration would be voluntary and plans choosing to participate would do so for both years. Under the demonstration, further guidance regarding the application process would be provided at a later date.

We have received questions about how plans should account for the possibility of a cha nge in the safe harborrules. For cy2020, cms is specifying the following practice and procedure with respect to the submission of bids: plan sponsors will submit bids for cy2020 in a form and manner that is consistent w ith the anti-kickback statute l aw and regulations in effect as of the bid submission deadline, including, for the purposes of bid development, the treatment of manufacturer rebates per our existing rules and guidance related to direct and indirect remuneration.

Date: April 17, 2019

Source: CMS.gov

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Major Payers Find HHS Finalized Nondiscrimination Rule Too NarrowMajor Payers Find HHS Finalized Nondiscrimination Rule Too Narrow
  • New Clinically Validated Sleepcheck App LaunchesNew Clinically Validated Sleepcheck App Launches
  • Apple Still has a Lot of Room to Grow in the $3.5 Trillion Health Care SectorApple Still has a Lot of Room to Grow in the $3.5 Trillion Health Care Sector
  • Google Moves Further Into Healthcare: a Timeline of the Last YearGoogle Moves Further Into Healthcare: a Timeline of the Last Year
  • Superb Healthcare At Ultra-Low Prices? How Singapore Does ItSuperb Healthcare At Ultra-Low Prices? How Singapore Does It
  • AI, Machine Learning, and Blockchain are Key for Healthcare InnovationAI, Machine Learning, and Blockchain are Key for Healthcare Innovation

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications